NASDAQ: TVTXTravere Therapeutics Inc Stock Ownership - Who owns Travere Therapeutics?
Insider buying vs selling
Have Travere Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christopher R. Cline | CHIEF FINANCIAL OFFICER | 2025-12-01 | 20,000 | $16.23 | $324.60kBuy |
| Christopher R. Cline | CHIEF FINANCIAL OFFICER | 2025-12-01 | 20,000 | $35.01 | $700.20kSell |
| Sandra Calvin | SVP CHIEF ACCOUNTING OFFICER | 2025-11-04 | 6,250 | $8.93 | $55.81kBuy |
| Sandra Calvin | SVP CHIEF ACCOUNTING OFFICER | 2025-11-04 | 12,500 | $22.40 | $280.00kBuy |
| Sandra Calvin | SVP CHIEF ACCOUNTING OFFICER | 2025-11-04 | 67,115 | $36.00 | $2.42MSell |
| Sandra Calvin | SVP CHIEF ACCOUNTING OFFICER | 2025-11-04 | 15,000 | $27.50 | $412.50kBuy |
| Sandra Calvin | SVP CHIEF ACCOUNTING OFFICER | 2025-11-04 | 17,500 | $26.88 | $470.40kBuy |
| Sandra Calvin | SVP CHIEF ACCOUNTING OFFICER | 2025-11-04 | 10,000 | $25.25 | $252.50kBuy |
| Timothy Coughlin | Director | 2025-10-31 | 10,000 | $17.44 | $174.40kBuy |
| Peter Heerma | CHIEF COMMERCIAL OFFICER | 2025-10-31 | 5,591 | $35.00 | $195.69kSell |
TVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TVTX insiders and whales buy or sell their stock.
TVTX Shareholders
What type of owners hold Travere Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ruth Shepley | 54.77% | 49,000,000 | $1.68B | Insider |
| Janus Henderson Group PLC | 11.85% | 10,599,660 | $363.46M | Institution |
| Blackrock Inc | 9.05% | 8,100,461 | $277.76M | Institution |
| Armistice Capital LLC | 7.52% | 6,724,000 | $230.57M | Institution |
| Vanguard Group Inc | 7.39% | 6,613,368 | $226.77M | Institution |
| Macquarie Group Ltd | 5.57% | 4,984,333 | $170.91M | Institution |
| Perceptive Advisors LLC | 4.24% | 3,794,615 | $130.12M | Institution |
| Adage Capital Partners GP LLC | 3.97% | 3,552,000 | $121.80M | Institution |
| State Street Corp | 3.60% | 3,217,839 | $110.34M | Institution |
| Fmr LLC | 3.23% | 2,894,148 | $99.24M | Institution |
TVTX vs Biotech Stocks
Travere Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.